FDA Clearance Tracker · P060010-S013
The Spanner Temporary Prostatic Stent
Last checked: Nov 20, 2026Latest source record: Oct 7, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 7, 2022
Approved
Time to decision
837 days
Received Jun 22, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P060010-S013
- Device name
- The Spanner Temporary Prostatic Stent
- Applicant
- Srs Medical
- Applicant location
- North Billerica, MA
- Received
- Jun 22, 2020
- Decided
- Oct 7, 2022
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P060010
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for the Spanner Prostatic Stent. The device is intended for temporary use (up to 30 days) to maintain urine flow and allow voluntary urination for patients who are not candidates for pharmacologic, minimally invasive or surgical treatment of the prostate.
Source documents
Other decisions for Srs Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CT3000Pro510(k)
K212830 · Decided Dec 21, 2021 · 105 days after receipt
Device type: Device, Cystometric, Hydraulic (FEN) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.